https://it.marketscreener.com/quotazioni/azione/ENANTA-PHARMACEUTICALS-IN-12855346/attualita/Enanta-Pharmaceuticals-Inc-Inizia-uno-studio-clinico-di-Fase-2b-di-EDP-938-in-adulti-ad-alto-risch-41923224/?utm_source=telegram&utm_medium=social&utm_campaign=share